U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 13:55:48 GMT 2023
Edited
by admin
on Sat Dec 16 13:55:48 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
AF75XOF6W3
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
RELATLIMAB
USAN   INN  
Official Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3 PROTEIN) (HUMAN HEAVY CHAIN), DISULFIDE WITH HUMAN LIGHT CHAIN, DIMER
Systematic Name English
BMS-986016
Code English
BMS-986213 COMPONENT RELATLIMAB
Common Name English
relatlimab [INN]
Common Name English
Relatlimab [WHO-DD]
Common Name English
RELATLIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE 3 PROTEIN (LAG-3, PROTEIN FDC, CD223 ANTIGEN))
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 641718
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
FDA ORPHAN DRUG 595017
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
NCI_THESAURUS C134305
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
Code System Code Type Description
DRUG BANK
DB14851
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
NCI_THESAURUS
C111999
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
CAS
1673516-98-7
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
INN
10735
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
RXCUI
2596773
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
DAILYMED
AF75XOF6W3
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
WIKIPEDIA
Relatlimab
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
FDA UNII
AF75XOF6W3
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
CAS
1683572-29-3
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
ALTERNATIVE
USAN
CD-174
Created by admin on Sat Dec 16 13:55:48 GMT 2023 , Edited by admin on Sat Dec 16 13:55:48 GMT 2023
PRIMARY
From To
1_22 1_95
1_147 1_203
1_261 1_321
1_367 1_425
2_22 2_95
2_147 2_203
2_261 2_321
2_367 2_425
1_134 3_214
1_226 2_226
1_229 2_229
2_134 4_214
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_297
N 2_297
Related Record Type Details
TARGET -> INHIBITOR
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER AVERAGE PHYSICAL
Molecular Formula CHEMICAL